Cargando…
Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson’s Disease
The gut microbiome can impact brain health and is altered in Parkinson’s disease (PD). The vermiform appendix is a lymphoid tissue in the cecum implicated in the storage and regulation of the gut microbiota. We sought to determine whether the appendix microbiome is altered in PD and to analyze the b...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823437/ https://www.ncbi.nlm.nih.gov/pubmed/33406628 http://dx.doi.org/10.3390/metabo11010029 |
_version_ | 1783639835221688320 |
---|---|
author | Li, Peipei Killinger, Bryan A. Ensink, Elizabeth Beddows, Ian Yilmaz, Ali Lubben, Noah Lamp, Jared Schilthuis, Meghan Vega, Irving E. Woltjer, Randy Pospisilik, J. Andrew Brundin, Patrik Brundin, Lena Graham, Stewart F. Labrie, Viviane |
author_facet | Li, Peipei Killinger, Bryan A. Ensink, Elizabeth Beddows, Ian Yilmaz, Ali Lubben, Noah Lamp, Jared Schilthuis, Meghan Vega, Irving E. Woltjer, Randy Pospisilik, J. Andrew Brundin, Patrik Brundin, Lena Graham, Stewart F. Labrie, Viviane |
author_sort | Li, Peipei |
collection | PubMed |
description | The gut microbiome can impact brain health and is altered in Parkinson’s disease (PD). The vermiform appendix is a lymphoid tissue in the cecum implicated in the storage and regulation of the gut microbiota. We sought to determine whether the appendix microbiome is altered in PD and to analyze the biological consequences of the microbial alterations. We investigated the changes in the functional microbiota in the appendix of PD patients relative to controls (n = 12 PD, 16 C) by metatranscriptomic analysis. We found microbial dysbiosis affecting lipid metabolism, including an upregulation of bacteria responsible for secondary bile acid synthesis. We then quantitatively measure changes in bile acid abundance in PD relative to the controls in the appendix (n = 15 PD, 12 C) and ileum (n = 20 PD, 20 C). Bile acid analysis in the PD appendix reveals an increase in hydrophobic and secondary bile acids, deoxycholic acid (DCA) and lithocholic acid (LCA). Further proteomic and transcriptomic analysis in the appendix and ileum corroborated these findings, highlighting changes in the PD gut that are consistent with a disruption in bile acid control, including alterations in mediators of cholesterol homeostasis and lipid metabolism. Microbially derived toxic bile acids are heightened in PD, which suggests biliary abnormalities may play a role in PD pathogenesis. |
format | Online Article Text |
id | pubmed-7823437 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-78234372021-01-24 Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson’s Disease Li, Peipei Killinger, Bryan A. Ensink, Elizabeth Beddows, Ian Yilmaz, Ali Lubben, Noah Lamp, Jared Schilthuis, Meghan Vega, Irving E. Woltjer, Randy Pospisilik, J. Andrew Brundin, Patrik Brundin, Lena Graham, Stewart F. Labrie, Viviane Metabolites Article The gut microbiome can impact brain health and is altered in Parkinson’s disease (PD). The vermiform appendix is a lymphoid tissue in the cecum implicated in the storage and regulation of the gut microbiota. We sought to determine whether the appendix microbiome is altered in PD and to analyze the biological consequences of the microbial alterations. We investigated the changes in the functional microbiota in the appendix of PD patients relative to controls (n = 12 PD, 16 C) by metatranscriptomic analysis. We found microbial dysbiosis affecting lipid metabolism, including an upregulation of bacteria responsible for secondary bile acid synthesis. We then quantitatively measure changes in bile acid abundance in PD relative to the controls in the appendix (n = 15 PD, 12 C) and ileum (n = 20 PD, 20 C). Bile acid analysis in the PD appendix reveals an increase in hydrophobic and secondary bile acids, deoxycholic acid (DCA) and lithocholic acid (LCA). Further proteomic and transcriptomic analysis in the appendix and ileum corroborated these findings, highlighting changes in the PD gut that are consistent with a disruption in bile acid control, including alterations in mediators of cholesterol homeostasis and lipid metabolism. Microbially derived toxic bile acids are heightened in PD, which suggests biliary abnormalities may play a role in PD pathogenesis. MDPI 2021-01-04 /pmc/articles/PMC7823437/ /pubmed/33406628 http://dx.doi.org/10.3390/metabo11010029 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Li, Peipei Killinger, Bryan A. Ensink, Elizabeth Beddows, Ian Yilmaz, Ali Lubben, Noah Lamp, Jared Schilthuis, Meghan Vega, Irving E. Woltjer, Randy Pospisilik, J. Andrew Brundin, Patrik Brundin, Lena Graham, Stewart F. Labrie, Viviane Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson’s Disease |
title | Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson’s Disease |
title_full | Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson’s Disease |
title_fullStr | Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson’s Disease |
title_full_unstemmed | Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson’s Disease |
title_short | Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson’s Disease |
title_sort | gut microbiota dysbiosis is associated with elevated bile acids in parkinson’s disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823437/ https://www.ncbi.nlm.nih.gov/pubmed/33406628 http://dx.doi.org/10.3390/metabo11010029 |
work_keys_str_mv | AT lipeipei gutmicrobiotadysbiosisisassociatedwithelevatedbileacidsinparkinsonsdisease AT killingerbryana gutmicrobiotadysbiosisisassociatedwithelevatedbileacidsinparkinsonsdisease AT ensinkelizabeth gutmicrobiotadysbiosisisassociatedwithelevatedbileacidsinparkinsonsdisease AT beddowsian gutmicrobiotadysbiosisisassociatedwithelevatedbileacidsinparkinsonsdisease AT yilmazali gutmicrobiotadysbiosisisassociatedwithelevatedbileacidsinparkinsonsdisease AT lubbennoah gutmicrobiotadysbiosisisassociatedwithelevatedbileacidsinparkinsonsdisease AT lampjared gutmicrobiotadysbiosisisassociatedwithelevatedbileacidsinparkinsonsdisease AT schilthuismeghan gutmicrobiotadysbiosisisassociatedwithelevatedbileacidsinparkinsonsdisease AT vegairvinge gutmicrobiotadysbiosisisassociatedwithelevatedbileacidsinparkinsonsdisease AT woltjerrandy gutmicrobiotadysbiosisisassociatedwithelevatedbileacidsinparkinsonsdisease AT pospisilikjandrew gutmicrobiotadysbiosisisassociatedwithelevatedbileacidsinparkinsonsdisease AT brundinpatrik gutmicrobiotadysbiosisisassociatedwithelevatedbileacidsinparkinsonsdisease AT brundinlena gutmicrobiotadysbiosisisassociatedwithelevatedbileacidsinparkinsonsdisease AT grahamstewartf gutmicrobiotadysbiosisisassociatedwithelevatedbileacidsinparkinsonsdisease AT labrieviviane gutmicrobiotadysbiosisisassociatedwithelevatedbileacidsinparkinsonsdisease |